{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:27:59Z","timestamp":1781857679539,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32DK007777"],"award-info":[{"award-number":["5T32DK007777"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences, NIH","doi-asserted-by":"crossref","award":["UL1 TR001064"],"award-info":[{"award-number":["UL1 TR001064"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1053\/j.ajkd.2016.07.023","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T22:01:51Z","timestamp":1474408911000},"page":"882-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A\u00a0Pilot Randomized Controlled Trial"],"prefix":"10.1053","volume":"68","author":[{"given":"Osama W.","family":"Amro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Noubary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2016.07.023_bib1","series-title":"The Kidney: Physiology and Pathophysiology","first-page":"2513","article-title":"Progression of autosomal dominant polycystic kidney disease (ADPKD) to renal failure","author":"Grantham","year":"2000"},{"key":"10.1053\/j.ajkd.2016.07.023_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2016.07.023_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2016.07.023_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1989.38","article-title":"The clinical utility of renal concentrating capacity in polycystic kidney disease","volume":"35","author":"Gabow","year":"1989","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2016.07.023_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.11311111","article-title":"Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment","volume":"7","author":"Zittema","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.07.023_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"3-4","key":"10.1053\/j.ajkd.2016.07.023_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"10.1053\/j.ajkd.2016.07.023_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2016.07.023_bib9","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/ndt\/gfr069","article-title":"Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug","volume":"26","author":"Meijer","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2016.07.023_bib10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2016.07.023_bib11","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2016.07.023_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000473076","article-title":"High fluid-low calcium intake: not all renal stone formers adhere to this simple treatment","volume":"5","author":"Fuss","year":"1979","journal-title":"Eur Urol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.07.023_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ki.2013.23","article-title":"The medicinal use of water in renal disease","volume":"84","author":"Wang","year":"2013","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2016.07.023_bib14","doi-asserted-by":"crossref","unstructured":"Verbalis JG. Disorders of water balance. In: Taal MW, Marsden PA, Skorecki K, Yu ASL, Brenner BM, eds. Brenner and Rector's The Kidney. 9th ed. Philadelphia, PA: Saunders, an imprint of Elsevier Inc; 2012; pp 540-542.","DOI":"10.1016\/B978-1-4160-6193-9.10015-6"},{"issue":"1","key":"10.1053\/j.ajkd.2016.07.023_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"issue":"2","key":"10.1053\/j.ajkd.2016.07.023_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2016.07.023_bib17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jc.2010-2499","article-title":"Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States","volume":"96","author":"Balanescu","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2016.07.023_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004872-199917030-00003","article-title":"Association of arginine vasopressin and arterial blood pressure in a population-based sample","volume":"17","author":"Zhang","year":"1999","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2016.07.023_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2215\/CJN.03401006","article-title":"Ethnic differences in urine concentration: possible relationship to blood pressure","volume":"2","author":"Bankir","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2016.07.023_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2016.07.023_bib21","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/01.ASN.0000025282.48298.7B","article-title":"The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease","volume":"13","author":"Belibi","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2016.07.023_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1677\/joe.0.1220535","article-title":"Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat","volume":"122","author":"Nicholson","year":"1989","journal-title":"J\u00a0Endocrinol"},{"issue":"11","key":"10.1053\/j.ajkd.2016.07.023_bib23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0002-8223(02)90346-9","article-title":"Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids","volume":"102","author":"Trumbo","year":"2002","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"1","key":"10.1053\/j.ajkd.2016.07.023_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2215\/CJN.03950510","article-title":"Water prescription in autosomal dominant polycystic kidney disease: a pilot study","volume":"6","author":"Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2016.07.023_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2215\/CJN.04180609","article-title":"A\u00a0pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease","volume":"5","author":"Barash","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2016.07.023_bib26","series-title":"R: A Language and Environment for Statistical Computing","year":"2014"},{"issue":"8901","key":"10.1053\/j.ajkd.2016.07.023_bib27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2016.07.023_bib28","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1046\/j.1523-1755.2002.00606.x","article-title":"The precision of estimating protein intake of patients with chronic renal failure","volume":"62","author":"Masud","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2016.07.023_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1985.10","article-title":"A\u00a0method for estimating nitrogen intake of patients with chronic renal failure","volume":"27","author":"Maroni","year":"1985","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2016.07.023_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2014.10.009","article-title":"Modifiable factors associated with copeptin concentration: a general population cohort","volume":"65","author":"van Gastel","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2016.07.023_bib31","article-title":"Diet and polycystic kidney disease: a pilot intervention study [published online ahead of print 2016]","author":"Taylor","year":"2016","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1053\/j.ajkd.2016.07.023_bib32","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2215\/CJN.03530411","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience","volume":"6","author":"Higashihara","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2016.07.023_bib33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/jes.2008.29","article-title":"Estimated daily average per capita water ingestion by child and adult age categories based on USDA's 1994-1996 and 1998 continuing survey of food intakes by individuals","volume":"19","author":"Kahn","year":"2009","journal-title":"J\u00a0Exposure Sci Environ Epidemiol"},{"issue":"3","key":"10.1053\/j.ajkd.2016.07.023_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","article-title":"Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort","volume":"61","author":"Boertien","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616303766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616303766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:51:23Z","timestamp":1759459883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616303766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0272638616303766"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.07.023","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A\u00a0Pilot Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}